Relationship between Inflammatory Cytokines and Uric Acid Levels with Adverse Cardiovascular Outcomes in Patients with Stable Coronary Heart Disease

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Rothenbacher, Dietrich ^a   Kleiner, Andrea ^a   Koenig, Wolfgang ^b   Primatesta, Paola ^c   Breitling, Lutz P ^d   Brenner, Hermann ^d  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; URIC ACID;

ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

ADULT; AGED; AREA UNDER CURVE; BAYES THEOREM; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY DISEASE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; URIC ACID;

EID: 84866668703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045907     Document Type: Article

References (25)

1. Koenig W, Khuseyinova N, (2007) Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 27: 15-26.
2. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, et al. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375: 132-140.
3. Krishnan E, (2010) Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology 49: 1229-1238.
4. Feig DI, Kang DH, Johnson RJ, (2008) Uric acid and cardiovascular risk. N Engl J Med 359: 1811-1821.
5. Martin WJ, Harper JL, (2010) Innate inflammation and resolution of gout. Immunol Cell Biol 88: 15-19.
6. Busso N, So A, (2010) Mechanisms of inflammation in gout. Arth Res Ther 12: 206.
7. Krishnan E, (2010) Inflammation, oxidative stress and lipids, the risk triad for atherosclerosis in gout. Rheumatology 49: 1229-1238.
8. Richette P, Bardin T, (2010) Gout. Lancet 375: 318-328.
9. Zhang QL, Brenner H, Koenig W, Rothenbacher D, (2010) Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations. Atherosclerosis 211: 342-347.
10. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-12.
11. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS, (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172.
12. Cook NR, (2010) Methods for evaluating novel biomarkers- a new paradigm. Int J Clin Pract 64: 1723-1727.
13. Cea Soriano L, Rothenbacher D, Choi HK, García Rodríguez LA, (2011) Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 13: R39.
14. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, et al. (2010) Hyperuricemia and coronary heart disease: A systematic review and meta-analysis. Arthritis Care & Res 62: 170-180.
15. Kim SY, Guevara JP, Kim KM, Choi HK, Heijtjan DF, et al. (2009) Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis &Rheumatism 61: 885-892.
16. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, et al. (2008) Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 125: 232-239.
17. Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, et al. (2011) Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One 6: e27817.
18. Yang Q, Köttgen A, Dehghan A, Smith AV, Glazer NL, et al. (2010) Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (3): 523-530.
19. Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, et al. (2011) Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider. Am J Kidney Dis 58: 398-408.
20. Chuang SY, Chen JH, Yeh WT, Wu CC, Pan WH, (2012) Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort. Int J Cardiol 154: 316-321.
21. Chen CC, Hsu YJ, Lee TM, (2011) Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia. Am J Physiol Heart Circ Physiol 301: H1107-117.
22. Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB,et al. Hyperuricemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J 2011; 32;712-720.
23. Elliot P, Chambers JC, Zhang W, Clarke R, Hopwell JC, et al. (2009) Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302: 37-48.
24. Casas JP, Shah T, Cooper J, Hawe E, McMahon AD, et al. (2006) Insight into the nature of the CRP-coronary events association using Mendelian randomization. Int J Epidemiol 35: 922-931.
25. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, et al. (2008) Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359: 1897-1908.